Categories: Uncategorized

Global Continuous Bioprocessing Market 2024-2033:

The Single-Use Bio Reactors Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Single-Use Bio Reactors Market:

https://www.thebusinessresearchcompany.com/report/singleuse-bioreactors-global-market-report

According to The Business Research Company’s Single-Use Bio Reactors Global Market Report 2024, The single-use bio reactors market size has grown rapidly in recent years. It will grow from $4.53 billion in 2023 to $5.39 billion in 2024 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to biopharmaceutical industry growth, rapid bioprocess development, regulatory support, high adoption rates of precision medicine, rise in healthcare infrastructure.

The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $11.28 billion in 2028 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to personalized medicine and gene therapies, growing of biopharmaceutical research and development, rising healthcare spending, increasing focus on research and development. Major trends in the forecast period include integration of sensors and analytics, closed-system design, customization and modularity, artificial intelligence (ai) and automation, hybrid facilities.

Increasing demand for pharmaceutical products is expected to propel the growth of the single-use bioreactor market going forward. Pharmaceutical products refer to medications or drugs that are specifically formulated to diagnose, prevent, treat, or cure diseases or medical conditions in humans or animals. Single-use bioreactors play a pivotal role in pharmaceutical production, especially in the manufacturing of biopharmaceuticals such as antibodies, vaccines, and gene therapies. For instance, in June 2022, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $351 billion (€300,000 million) in 2021, with an increase of approximately 5% from $335.2 billion (€286,697 million) in 2020. Therefore, increasing demand for pharmaceutical products is driving the growth of the single-use bioreactor market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=6035&type=smp

The single-use bio reactors market covered in this report is segmented –

1) By Type: Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs, Other Types

2) By Molecule Type: Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins

3) By Cell Type: Mammalian Cell, Bacteria, Yeast

4) By Application: Research And Development (R&D), Process Development, Bioproduction

5) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Contract Manufacturing Organizations (CMO)

Product innovations are a key trend gaining popularity in the single-use bioreactor market. Major companies in the market are focusing on launching innovative products for market growth. For instance, in March 2021, Thermo Fisher Scientific Inc., a US-based scientific research and laboratory services company, introduced single-use bioreactors with capacities of 3,000 liters and 5,000 liters, surpassing the conventional size limitations. This response was driven by the significant demand from contract development and manufacturing organizations (CDMOs) and pharmaceutical firms seeking various system sizes. These new systems offer increased scalability, an improved turndown ratio, and enhanced mixing capabilities.

The single-use bio reactors market report table of contents includes: